Methods for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders

Details for Australian Patent Application No. 2006230419 (hide)

Owner Targeted Genetics Corporation

Inventors Giannobile, William V.; Burstein, Haim

Agent FB Rice

Pub. Number AU-A-2006230419

PCT Pub. Number WO2006/105344

Priority 60/667,388 31.03.05 US

Filing date 30 March 2006

Wipo publication date 5 October 2006

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105344 Priority application(s): WO2006/105344

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230420-Compositions and methods for the control, prevention, and treatment of obesity and eating disorders

2006230413-Fc variants with optimized properties